Zimbabwe has rejected a substantial US health deal worth 367 million US dollars (272 million pounds) over five years because of Washington's insistence on confidential information.
This rejection was revealed following a official document dated December was disclosed, which showed Head of State Emmerson Mnangagwa believed the arrangement was "lopsided".
A government spokesperson later explained that the US was seeking biological samples for scientific study and commercial purposes while refused to guarantee the benefits from future vaccines.
"We must now begin the challenging and unfortunate task of scaling back our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had furnished over $1.9bn as health assistance to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has called for further talks to reach a deal acceptable to both sides so the country's critical HIV programme can be sustained.
Broader Context
This rejection follows a similar case in neighbouring Kenya, where a court blocked a related health funding agreement after legal challenges were raised about the safety of citizens' medical information.
Since returning to office recently, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
USAID had managed assistance for the US government, but Trump claimed its expenditure was "inefficient" and his administration was seeking direct bilateral agreements to boost transparency and accountability.
As per reports, Sixteen African countries have to date agreed to similar health pacts, representing more than $18.3bn of fresh investment.
Specifics of the Rejected Deal
The funds for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this collaboration would have delivered extraordinary advantages for the people of Zimbabwe, especially the 1.2 million presently receiving HIV treatment via US-supported programmes," the Ambassador said.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"Our nation was requested to surrender its biological resources and data for a long time, with no corresponding guarantee of benefiting from any medical innovations – like new medicines or tests – that could be developed from that shared data," Mangwana explained.
"Put simply, our nation would supply the raw materials for medical research without any assurance that the final treatments would be available to our citizens if a new disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further pointed out that the American exit from the global health body and its pursuit of bilateral health agreements were disrupting frameworks previously set up through the international health agency.
Mangwana cited its Pandemic Benefit-Sharing system designed to deal with future global health emergencies.
"This mechanism is designed to ensure that when a nation contributes its information, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the capability to create them."
These objections regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We are open to continued dialogue with our American counterparts on how future collaboration might be structured in a way that respects the sovereignty and interests of each country."
Medical Community Response
A leading public health body expressed it recognised the government's concerns, but urged that negotiations must proceed considering much of the nation's HIV programmes relied on international support.
"Where specific concerns exist, such as those involving data governance or agreement terms, these can frequently be addressed through detailed discussion and negotiated safeguards," it commented.
The halted deal underscores the complex debate between accepting crucial foreign assistance and protecting a country's data in an ever more interconnected world.